Health
New drug candidate suppresses SARS-CoV-2 replication – News-Medical.Net
Researchers at Stanford University and Utah State University have developed a novel inhibitor of the coronavirus main protease (Mpro) that effectively suppresses the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Researchers at Stanford University and Utah State University have developed a novel inhibitor of the coronavirus main protease (Mpro) that effectively suppresses the viral replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
SARS-CoV-2 is the agent that causes coronavirus disease 2019 (COVID-19), and Mpro is an essential protein required for the life cycle of coronaviruses.
Currently, there is an intense interest in discovering effective inhibitors of SARS-CoV-2 Mpro. S…
-
Noosa News22 hours agoMega-team of heavy horses sets world record at Good Old Days Festival
-
Noosa News15 hours agoNRL grand final quick hits: Reece Walsh creates magic after avoiding sin bin as Broncos survive Hunt, Reynolds injuries to win premiership
-
General15 hours agoHow the internet reacted to Brisbane Broncos winning the NRL grand final
-
Noosa News24 hours agoCampers evacuated as fire crews battle blaze